Biolegend, 480039, MojoSort™ Mouse CD4 Naïve T Cell Isolation Kit
20tests
Catalog Number: 480039
Send an RFQ.
Category
| Verified Reactivity | Mouse |
|---|---|
| Formulation | Cocktail: Phosphate buffer solution containing 0.09% sodium azide, pH 7.2.Streptavidin Nanobeads: Aqueous solution containing BSA and 0.05% sodium azide. |
| Preparation | The antibodies were purified by affinity chromatography, and conjugated with biotin under optimal conditions.Strepavidin Nanobeads: Streptavidin-coated magnetic beads. |
| Storage & Handling | Antibody cocktail and Streptavidin Nanobeads should be stored undiluted between 2°C and 8°C. |
| Application | Cell Separation (MojoSort™) - Quality tested |
| Recommended Usage | 10 µl of antibody cocktail for 1 x 107 cells in 100 µl of buffer. 10 µl of Streptavidin Nanobeads for 1 x 107 cells in 100 µl of buffer. |
| Application Notes | This kit is designed for the isolation of untouched naïve CD4+ T cells from lymphoid tissues. For optimal results, we recommend incubating the sample in PBS without Ca/Mg on ice for 30 minutes at the final step of the sample preparation procedure. See the protocols for further instructions. Each lot has been individually optimized. Do not mix and match components from different lots or different kits. Antibody or cocktail dilution to use in column: 8X Nanobead dilution to use in columns: 5X |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Product Citations |
|---|
| Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed Sang H, et al. 2023. Adv Clin Exp Med. 32:551. PubMed Dou D, et al. 2021. Clin Sci (Lond). 135:597. PubMed Hsieh T, et al. 2022. Front Immunol. 13:901030. PubMed Chen C, et al. 2022. Sci Adv. 8:eabo4363. PubMed Guo F, et al. 2022. Appl Microbiol Biotechnol. 106:7643. PubMed Reticker-Flynn NE, et al. 2022. Cell. 185:1924. PubMed Kiritsy MC, et al. 2021. Elife. 10:. PubMed Dong L, et al. 2017. Sci Rep. 10.1038/srep36598. PubMed Kang S, et al. 2021. Bio Protoc. 11:e4029. PubMed Duan H, et al. 2021. J Clin Invest. 131:. PubMed Tian M, et al. 2021. Elife. 10:. PubMed Nagata K, et al. 2021. Front Immunol. 12:730706. PubMed Blaszczak AM, et al. 2020. Immunometabolism. 2:00. PubMed Feng P, et al. 2021. Theranostics. 11:9503. PubMed Jain A, et al. 2020. Nat Immunol. 0.920138889. PubMed Lee WH, et al. 2019. Exp Mol Med. 51:143. PubMed Wang N, et al. 2020. Front Immunol. 1.765972222. PubMed |
| Biology Area | Immunology |
|---|
| Molecular Family | CD Molecules |
|---|
| Gene ID | NA |
|---|
| UniProt | View information about CD4 on UniProt.org |
|---|
| Regulatory Status | RUO |
|---|